Pathological outcomes in women with cervical adenocarcinoma In Situ treated by conisation or conisation followed by hysterectomy
Authors:
- Lan Ying LiLLLan Ying Li
- Da Long SongDSDa Long Song
- Xiao Ying SunXSXiao Ying Sun
- Zhi Gang LiZLZhi Gang Li
- Ke Li YouKYKe Li You
Open Access
- 27 January 2026
- journal article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16
Abstract
Objective: This study aimed to evaluate the pathological outcomes of conisation with or without subsequent hysterectomy in patients diagnosed with adenocarcinoma in situ (AIS) and grade 3 cervical intraepithelial neoplasia (CIN3), emphasizing the impact of margin status on residual disease and recurrence risk. Methods: A retrospective analysis was conducted on patients diagnosed with AIS and CIN3 who underwent loop electrosurgical excision procedure (LEEP) or cold-knife conisation (CKC) between January 2012 and December 2022. The pathological findings of conisation and subsequent hysterectomy, as well as recurrence rates in patients managed conservatively, were analyzed. Patients were followed for a minimum of 3 years, with recurrence defined as the detection of cervical intraepithelial neoplasia (CIN) through colposcopy. Results: A total of 387 patients were included: 107 with AIS and 280 with CIN3. Hysterectomy was performed in 72.9% of AIS patients and 49.3% of CIN3 patients after conisation. Positive conisation margins were associated with a higher likelihood of residual disease in hysterectomy specimens, especially in cases with cervical canal involvement in AIS (70.0%) and with combined endo/ectocervical and canal margin involvement in CIN3 (60.0%). In multivariable logistic regression analysis adjusting for age, HPV status, and conisation technique, cervical canal margin involvement was independently associated with positive hysterectomy pathology in AIS (OR 6.962, 95% CI 1.393–34.794; p = 0.018), whereas endo/ectocervical margin involvement was the independent predictor in CIN3 (OR 6.790, 95% CI 1.683–27.387; p = 0.007). The preoperative HPV infection rate was lower in AIS than in CIN3 (88.8% vs 97.1%, p = 0.002). Conclusion: While hysterectomy is recommended for AIS with positive margins, conisation alone may be a safe alternative for selected patients without involvement of the cervical canal margin.Keywords
This publication has 27 references indexed in Scilit:
- Cost-effectiveness of an additional hysterectomy after initially conservative treatment for cervical adenocarcinoma in situGynecologic Oncology, 2025
- Nationwide cohort study on the risk of high‐grade cervical dysplasia and carcinoma after conservative treatment or hysterectomy for adenocarcinoma in situInternational Journal of Cancer, 2024
- Exploring uterine involvement in hysterectomy samples following conization for adenocarcinoma in situ of the uterine cervix: Insights from a multicenter study by the FRANCOGYN groupJournal of Gynecology Obstetrics and Human Reproduction, 2024
- Follow-up of women with cervical adenocarcinoma in situ treated by conization: A single centre clinical experienceGynecologic Oncology, 2024
- European consensus statement on expert colposcopyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2023
- The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinomaGynecologic Oncology, 2023
- Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008–2015International Journal of Cancer, 2019
- Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004–2013Cancer Medicine, 2017
- Cervical Cancer Trends in the United States: A 35-Year Population-Based AnalysisJournal of Women's Health, 2012
- Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin statusAmerican Journal of Obstetrics and Gynecology, 2009